These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35842060)

  • 1. A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay - Exemplified for nine compounds.
    Gampfer TM; Wagmann L; Pulver B; Westphal F; Flockerzi V; Meyer MR
    Toxicology; 2022 Jun; 476():153258. PubMed ID: 35842060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of new psychoactive substances and other drugs of abuse studied in human HepG2 cells using an adopted high content screening assay.
    Richter LHJ; Beck A; Flockerzi V; Maurer HH; Meyer MR
    Toxicol Lett; 2019 Feb; 301():79-89. PubMed ID: 30465810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity, metabolism, and isozyme mapping of the synthetic cannabinoids JWH-200, A-796260, and 5F-EMB-PINACA studied by means of in vitro systems.
    Gampfer TM; Wagmann L; Belkacemi A; Flockerzi V; Meyer MR
    Arch Toxicol; 2021 Nov; 95(11):3539-3557. PubMed ID: 34453555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
    Grafinger KE; Hädener M; König S; Weinmann W
    Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
    O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
    Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, "LC-(High Resolution)-MSn" and "LC-(High Resolution)-MS/MS".
    A Michely JA; Manier SK; Caspar AT; Brandt SD; Wallach J; Maurer HH
    Curr Neuropharmacol; 2017; 15(5):692-712. PubMed ID: 27758707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved.
    Tolosa L; Gómez-Lechón MJ; Pérez-Cataldo G; Castell JV; Donato MT
    Arch Toxicol; 2013 Jun; 87(6):1115-27. PubMed ID: 23397584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Drug-Induced Liver Injury in HepG2 Cells Cultured with Human Liver Microsomes.
    Choi JM; Oh SJ; Lee JY; Jeon JS; Ryu CS; Kim YM; Lee K; Kim SK
    Chem Res Toxicol; 2015 May; 28(5):872-85. PubMed ID: 25860621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Psychoactive Substance 5-MeO-MiPT In vivo Acute Toxicity and Hystotoxicological Study.
    Altuncı YA; Aydoğdu M; Açıkgöz E; Güven Ü; Düzağaç F; Atasoy A; Dağlıoğlu N; Annette Akgür S
    Balkan Med J; 2021 Jan; 38(1):34-42. PubMed ID: 32936075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examples.
    Richter LHJ; Flockerzi V; Maurer HH; Meyer MR
    J Pharm Biomed Anal; 2017 Sep; 143():32-42. PubMed ID: 28601767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Fluoromethamphetamine (4-FMA) induces in vitro hepatotoxicity mediated by CYP2E1, CYP2D6, and CYP3A4 metabolism.
    Roque Bravo R; Carmo H; Valente MJ; Silva JP; Carvalho F; Bastos ML; Dias da Silva D
    Toxicology; 2021 Nov; 463():152988. PubMed ID: 34655687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings-A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish Larvae.
    Wagmann L; Frankenfeld F; Park YM; Herrmann J; Fischmann S; Westphal F; Müller R; Flockerzi V; Meyer MR
    Front Chem; 2020; 8():539. PubMed ID: 32766204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
    Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
    Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity and apoptosis induced by silver nanoparticles in human liver HepG2 cells in different dispersion media.
    Xue Y; Zhang T; Zhang B; Gong F; Huang Y; Tang M
    J Appl Toxicol; 2016 Mar; 36(3):352-60. PubMed ID: 26198703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.
    Michely JA; Helfer AG; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Oct; 407(25):7831-42. PubMed ID: 26297461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of silica nanoparticles on cadmium-induced cytotoxicity, oxidative stress, and apoptosis in human liver HepG2 cells.
    Ahamed M; Akhtar MJ; Alhadlaq HA
    Environ Toxicol; 2020 May; 35(5):599-608. PubMed ID: 31904905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury.
    Tolosa L; Jiménez N; Pérez G; Castell JV; Gómez-Lechón MJ; Donato MT
    Arch Toxicol; 2018 Jan; 92(1):383-399. PubMed ID: 28762043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures.
    Yokoyama Y; Sasaki Y; Terasaki N; Kawataki T; Takekawa K; Iwase Y; Shimizu T; Sanoh S; Ohta S
    Biol Pharm Bull; 2018 May; 41(5):722-732. PubMed ID: 29445054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upgrading cytochrome P450 activity in HepG2 cells co-transfected with adenoviral vectors for drug hepatotoxicity assessment.
    Tolosa L; Donato MT; Pérez-Cataldo G; Castell JV; Gómez-Lechón MJ
    Toxicol In Vitro; 2012 Dec; 26(8):1272-7. PubMed ID: 22138474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cytochrome P450s (CYP)-overexpressing HepG2 cells for assessing drug and chemical-induced liver toxicity.
    Chen S; Wu Q; Li X; Li D; Mei N; Ning B; Puig M; Ren Z; Tolleson WH; Guo L
    J Environ Sci Health C Toxicol Carcinog; 2021; 39(1):68-86. PubMed ID: 33576714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.